Britt trust plans $10M Chime stock sale
Chime Financial, Inc. (CHYM) is named as the issuer in a Form 144 notice filed for planned sales of its common stock by the Britt Living Trust.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Chime Financial, Inc. (CHYM) is named as the issuer in a Form 144 notice filed for planned sales of its common stock by the Britt Living Trust. The trust has given notice of intent to sell up to 300,000 shares of Chime common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $10,008,000.00 and an expected sale date of 08/28/2026. The shares to be sold were acquired on 08/28/2012 via previously exercised stock options. Over the past three months, related 10b5-1 plan sales have totaled 550,000 shares of Chime common stock for aggregate proceeds of $16,462,960.00, including sales by Alexandra Britt and the Britt Living Trust.
Key Figures
Key Terms
Form 144 regulatory
Rule 144 regulatory
10b5-1 regulatory
Previously Exercised Stock Options financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock sale is being reported for Chime Financial, Inc. (CHYM) in this Form 144?
What recent 10b5-1 plan sales of CHYM stock are disclosed for the Britt Living Trust?
What CHYM stock sale involving Alexandra Britt is reported in the past three months?
AI-generated analysis. How Rhea-AI works. Not financial advice.